This expression can make T lymphocytes more susceptible to MIF signaling and to CD74-dependent activation, since also the signaling coreceptor molecules CXCR2 and CXCR4 were enhanced on T cells in COVID-19 patients (Figures 2E, F). The gene discussed is MIF; the disease is COVID-19.